Brady releases “Sample Certainty” White Paper on how specimen labeling impacts productivity & cost
Report explores current trends in science & medicine that will change the way your lab runs
Brady (NYSE:BRC), a global leader in product and facility identification solutions, today released its “Sample Certainty” white paper. The report explains important aspects of sample labeling, including the cost of sample loss, common sample errors and best practices for labeling and tracking samples.
“As science continues to advance, the amount of samples being processed in the lab and sent between labs is growing. In order to keep these samples safe and the information on labels clear and intact, effective labeling and tracking processes must be established,” says Dana Ray, global market manager, lab and medical for Brady. “When labels fail in the middle of a research project, lab technicians and managers are faced with inconveniences ranging from minor slowdowns to major devastation. These setbacks can incur costs, impact patient care or disrupt important research, but with the proper label materials and processes in place, this problem can be avoided.”